Physiotherapy After Botulinum Toxin Injection and Serial Casting
Comparison of the Effectiveness of Different Physiotherapy and Rehabilitation Programs After Onabotulinum Toxin-A Injection and Serial Casting in Children With Cerebral Palsy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: pelin atalan, MsC
- Phone Number: +905076856154
- Email: plntln@hotmail.com
Study Locations
-
-
Bornova
-
İ̇zmi̇r, Bornova, Turkey, 35050
- Pelin Atalan
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being diagnosed with cerebral palsy (CP) (hemiplegic-diplegic)
- To have undergone botulinum toxin and serial casting interventions in the last 2 months
- to be between 5-10 years old
- Being at the level of I-II-III (ambulatory or assisted ambulatory) according to Gross Motor Function Classification System
- To have the mental competence to understand and apply assessments and exercises
Exclusion Criteria:
- Having undergone surgery involving the lower extremity in the last 6 months
- Refusing to participate in the study
- Having other accompanying neurometabolic or orthopedic disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: control group
Children in this group will take routine physiotherapy (stretching, strengthening) program during 6 weeks.
3 days/week.
|
Children in one of the groups will take routine physiotherapy programme
|
|
Active Comparator: intervention group
Children in this group will take routine physiotherapy (stretching, strengthening) program + backward downhill walking (10 minutes in a day) during 6 weeks.
3 days/week.
|
Children in one of the groups will take routine physiotherapy programme
Children in the intervention group will take backward downhill walking program plus to routine physiotherapy.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle morphology
Time Frame: Before the intervention
|
Muscle thickness, cross sectional area, fiber length, pennation angle will be recorded by ultrasonographic measurements
|
Before the intervention
|
|
Muscle morphology
Time Frame: After six weeks intervention
|
Muscle thickness, cross sectional area, fiber length, pennation angle will be recorded by ultrasonographic measurements
|
After six weeks intervention
|
|
Vascularization
Time Frame: Before the the intervention
|
Muscle vascularization will be recorded by Suberb Microvascular Imaging (SMI) method via ultrasonographic measurements
|
Before the the intervention
|
|
Vascularization
Time Frame: After six weeks intervention
|
Muscle vascularization will be recorded by Suberb Microvascular Imaging (SMI) method via ultrasonographic measurements
|
After six weeks intervention
|
|
Muscle strenght
Time Frame: Before the intervention
|
Will be measured by manual muscle tester
|
Before the intervention
|
|
Muscle strenght
Time Frame: After six weeks intervention
|
Will be measured by manual muscle tester
|
After six weeks intervention
|
|
Range of motion
Time Frame: Before the intervention.
|
Will be measured with goniometer
|
Before the intervention.
|
|
Range of motion
Time Frame: After six weeks intervention
|
Will be measured with goniometer
|
After six weeks intervention
|
|
Edinburgh visual gait analysis
Time Frame: Before the intervention
|
Gait will be recorded as video and this video will be scored
|
Before the intervention
|
|
Edinburgh visual gait analysis
Time Frame: After six weeks intervention
|
Gait will be recorded as video and this video will be scored
|
After six weeks intervention
|
|
Modified Tardieu Scale
Time Frame: Before the intervention
|
Lower extremity spasticity will be mesured with this scale.
Higher scores mean more intensive spasticity
|
Before the intervention
|
|
Modified Tardieu Scale
Time Frame: After six weeks intervention
|
Lower extremity spasticity will be mesured with this scale.
Higher scores mean more intensive spasticity
|
After six weeks intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic data
Time Frame: Before the intervention
|
Face-to-face interview with family.
Will be recorded in data registration form
|
Before the intervention
|
|
Demographic data
Time Frame: After six weeks intervention
|
Face-to-face interview with family.
Will be recorded in data registration form
|
After six weeks intervention
|
|
Child Health Questionnare (Parent form)
Time Frame: Before the intervention
|
Quality of life will be measured by this questionnare
|
Before the intervention
|
|
Child Health Questionnare (Parent form)
Time Frame: After six weeks intervention
|
Quality of life will be measured by this questionnare
|
After six weeks intervention
|
|
Children Functional Independence Measurement Scale
Time Frame: Before the intervention
|
Functional Independency will be measured by this scale.
Higher scores mean better independence.
|
Before the intervention
|
|
Children Functional Independence Measurement Scale
Time Frame: After six weeks intervention
|
Functional Independency will be measured by this scale.
Higher scores mean better independence.
|
After six weeks intervention
|
|
Lower extremity selective control measurement
Time Frame: Before the intervention
|
Selective movement will be measured with this scale.
Higher scores mean better selective control.
|
Before the intervention
|
|
Lower extremity selective control measurement
Time Frame: After six weeks intervention
|
Selective movement will be measured with this scale.
Higher scores mean better selective control.
|
After six weeks intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GaziUniPA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.